相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Association of Kidney Disease Outcomes With Risk Factors for CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
Wei Yang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Spironolactone to Prevent Peritoneal Fibrosis in Peritoneal Dialysis Patients: A Randomized Controlled Trial
Armando Vazquez-Rangel et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Management of Hyperkalemia in Hospitalized Patients
Kristy N. Fordjour et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2014)
Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
Miklos Z. Molnar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
Yoshihiro Matsumoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients
Yasuhiko Ito et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa)
Fabian Hammer et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Serum Potassium Levels and Its Variability in Incident Peritoneal Dialysis Patients: Associations with Mortality
Qingdong Xu et al.
PLOS ONE (2014)
Efficacy and Safety of Combined vs. Single Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease: A Meta-Analysis
Paweena Susantitaphong et al.
AMERICAN JOURNAL OF HYPERTENSION (2013)
Gastrointestinal Adverse Events with Sodium Polystyrene Sulfonate (Kayexalate) Use: A Systematic Review
Ziv Harel et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
Bertram Pitt et al.
EUROPEAN HEART JOURNAL (2013)
Spironolactone improves endothelial and cardiac autonomic function in non heart failure hemodialysis patients
Panayota Flevari et al.
JOURNAL OF HYPERTENSION (2013)
The clinical significance of hyperkalaemia-associated repolarization abnormalities in end-stage renal disease
Darren Green et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Hyperkalemia: getting to the heart of the matter
Amanda Welch et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
Harikrishna Makani et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Association of Prescription of Oral Sodium Polystyrene Sulfonate With Sorbitol in an Inpatient Setting With Colonic Necrosis: A Retrospective Cohort Study
Maura A. Watson et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Secondary Prevention of Hyperkalemia With Sodium Polystyrene Sulfonate in Cardiac and Kidney Patients on Renin-Angiotensin-Aldosterone System Inhibition Therapy
Gil Chernin et al.
CLINICAL CARDIOLOGY (2012)
Kayexalate-Induced Esophageal Ulcer in a Patient With Gastroparesis
Emmanuel C. Gorospe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Prevalence and Factors Associated with Hyperkalemia in Predialysis Patients Followed in a Low-Clearance Clinic
Pantelis A. Sarafidis et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Modifiable Practices Associated with Sudden Death among Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study
Michel Jadoul et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Dead Man Walking An Extreme Case of Sinusoidal Wave Pattern in Severe Hyperkalemia
Joao Silva Marques et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Metabolic Complications in Elderly Adults with Chronic Kidney Disease
Paul E. Drawz et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Asking the question again: are cation exchange resins effective for the treatment of hyperkalemia?
S. Kamel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Association of Hypo- and Hyperkalemia with Disease Progression and Mortality in Males with Chronic Kidney Disease: The Role of Race
John Hayes et al.
NEPHRON CLINICAL PRACTICE (2012)
An Electrocardiographic Sine Wave in Hyperkalemia
Daniel B. Petrov
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission
Jamie L. Fleet et al.
BMJ OPEN (2012)
PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016
Jerry M. Buysse et al.
FUTURE CARDIOLOGY (2012)
Effect of eplerenone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric chronic hemodialysis patients - a pilot study
L. Shavit et al.
CLINICAL NEPHROLOGY (2011)
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
Y. Miao et al.
DIABETOLOGIA (2011)
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
Bertram Pitt et al.
EUROPEAN HEART JOURNAL (2011)
Hyperkalaemia, pseudohyperkalaemia and electrocardiographic correlates
Eftychios Siniorakis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics
Patrick H. Pun et al.
KIDNEY INTERNATIONAL (2011)
Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibitors
Matthew R. Weir et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
A Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone on Carotid Intima-Media Thickness in Nondiabetic Hemodialysis Patients
Antonio Vukusich et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Damned If You Do, Damned If You Don't: Potassium Binding Resins in Hyperkalemia
Maura Watson et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study
Sonal Korgaonkar et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Ion-Exchange Resins for the Treatment of Hyperkalemia: Are They Safe and Effective?
Richard H. Sterns et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Risk of Hyperkalemia in Nondiabetic Patients With Chronic Kidney Disease Receiving Antihypertensive Therapy
Joy M. Weinberg et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Lisa M. Einhorn et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Colonic Mucosal Necrosis Following Administration of Calcium Polystryrene Sulfonate (Kalimate) in a Uremic Patient
Mee Joo et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
Retrospective review of the frequency of ECG changes in hyperkalemia
Brian T. Montague et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Management of severe hyperkalemia
Lawrence S. Weisberg
CRITICAL CARE MEDICINE (2008)
Serum and dialysate potassium concentrations and survival in hemodialysis patients
Csaba P. Kovesdy et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Predictors of survival after cardiac arrest in outpatient hemodialysis clinics
Patrick H. Pun et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Efficacy and safety of benazepril for advanced chronic renal insufficiency
FF Hou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure
KB Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial
P Ruggenenti et al.
LANCET (2005)
Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression
PJ Heering et al.
CLINICAL TRANSPLANTATION (2004)
Rates of hyperkalemia after publication of the randomized aldactone evaluation study
DN Juurlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
BF Palmer
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension - A report of the Japanese losartan therapy intended for the global renal protection in hypertensive patients (JLIGHT) study
Y Iino et al.
HYPERTENSION RESEARCH (2004)
Complications of inappropriate use of spiroholactone in heart failure: When an old medicine spirals out of new guidelines
B Bozkurt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients
GA Knoll et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial
JFE Mann et al.
ANNALS OF INTERNAL MEDICINE (2001)
ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure
GL Bakris et al.
KIDNEY INTERNATIONAL (2000)
Hypertonic saline treatment of severe hyperkalemia in nonnephrectomized dogs
JL Kaplan et al.
ACADEMIC EMERGENCY MEDICINE (2000)